EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics

Hassan Albadawi, Zefu Zhang, Hyeongseop Keum, Enes Cevik, Bolni M Nagalo, Seyda Gunduz, Hirohito Kita, Rahmi Oklu iD

Advanced Materials · 2024

DOI: 10.1002/adma.202406080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Hassan Albadawi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, 13400 East Shea Blvd., Scottsdale, AR, 852…. Hauptthemen laut MEDLINE: Doxorubicin, Liver Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced‐stage liver cancers are associated with poor prognosis and have limited treatment options, often leading the patient to hospice care. Percutaneous intratumoral injection of anticancer agents has emerged as a potential alternative to systemic therapy to overcome tumor barriers, increase bioavailability, potentiate immunotherapy, and avoid systemic toxicity, which advanced‐stage cancer patients cannot tolerate. Here, an injectable OncoGel (OG) comprising of a nanocomposite hydrogel loaded with an ionic liquid (IL) is developed for achieving a predictable and uniform tumor ablation and long‐term slow release of anticancer agents into the ablation zone. Rigorous mechanical, physiochemical, drug release, cytotoxicity experiments, and ex vivo human tissue testing identify an injectable version of the OG with bactericidal properties against highly resistant bacteria. Intratumoral injection of OG loaded with Nivolumab (Nivo) and doxorubicin (Dox) into highly malignant tumor models in mice, rats, and rabbits demonstrates enhanced survival and tumor regression associated with robust tissue ablation and drug distribution throughout the tumor. Mass cytometry and proteomic studies in a mouse model of colorectal cancer that often metastasizes to the liver indicate an enhanced anticancer immune response following the intratumoral injection of OG. OG may augment immunotherapy and potentially improve outcomes in liver cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinLiver NeoplasmsAnimalsMiceHumansRabbitsRatsHydrogelsCell Line, TumorDelayed-Action PreparationsAntineoplastic AgentsDrug LiberationIonic LiquidsAblation Techniques

Stichwörter der Autor:innen

ablationbiomaterialdrug deliveryintratumoralliver cancer

Substanzen

DoxorubicinHydrogelsDelayed-Action PreparationsAntineoplastic AgentsIonic Liquids

Autor:innen und Institutionen

  • Division of Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, 13400 East Shea Blvd., Scottsdale, AR, 85259, USA.
  • University of Arkansas for Medical Sciences, College of Medicine, Department of Pathology, 301 West Markham Street, Little Rock, AR, 72205, USA.
  • Department of Medical Oncology, Istinye University; Bahcesehir Liv Hospital, Istanbul, 34517, Turkey.
  • Department of Immunology, Division of Allergy, Asthma, and Clinical Immunology and the Department of Medicine, Mayo Clinic Arizona, Scottsdale, AR, 85259, USA.

ORCID-Profile: Rahmi Oklu

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • Mayo Clinic: Christian Haub Family Career Development Award and the Mayo Clinic Clinician Investigator Award
  • National Institutes of Health

Zitieren

APA

Albadawi, H., Zhang, Z., Keum, H., Cevik, E., Nagalo, B. M., Gunduz, S., Kita, H., & Oklu, R. (2024). Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics. Advanced Materials. https://doi.org/10.1002/adma.202406080

Vancouver

Albadawi H, Zhang Z, Keum H, Cevik E, Nagalo BM, Gunduz S, et al. Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics. Advanced Materials. 2024. doi:10.1002/adma.202406080

BibTeX
@article{Albadawi2024,
  author = {Albadawi, Hassan and Zhang, Zefu and Keum, Hyeongseop and Cevik, Enes and Nagalo, Bolni M and Gunduz, Seyda and Kita, Hirohito and Oklu, Rahmi},
  title = {Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202406080}
}
Kostenlos starten →